Treatment of impaired perfusion in septic shock

References

• Reyes WJ, Brimioulle S, Vincent JL: Septic shock without documented infection: an uncommon entity with a high mortality. ACCP/SCCM Consensus Conference Committee. Intensive Care Med 1999; 25: 1267–70.
   PubMed Web of Science ®Google Scholar
• Bone RC, Balk RA, Cerra FB, Dellinger RP, Fein AM, Knaus WA, et at And ACCP/SCCM Consensus Conference Committee. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Chest 1992; 101: 1656–62.
   PubMed Web of Science ®Google Scholar
• Angus DC, Linde-Zwirble WT, Lidicker J, Clermont G, Carcillo J, Pinsky MR. Epidemiology of severe sepsis in the United States: analysis of incidence, outcome and associated costs of care. Crit Care Med 2001; 29: 1303–10.
   PubMed Web of Science ®Google Scholar
• Brun-Buisson C. The epidemiology of the systemic inflam-matory response. Intensive Care Med 2000; 26: S64–74.
   PubMed Web of Science ®Google Scholar
• Hayes MA, Timmins AC, Yau EH, Hayes MA, Timmins AC, Yau EH, et al. oxygen transport patterns in patients with sepsis syndrome or septic shock. Influence of treatment and relationship to outcome. Crit Care Med 1997; 25: 926–36.
   PubMed Web of Science ®Google Scholar
• Steffes CP, Dalin MS, Lange MP. Oxygen transport-dependent splanchnic metabolism in the sepsis syndrome. Arch Surg 1994; 129: 46–52.
   PubMedGoogle Scholar
• Rackow E, Astiz ME, Weil MH. Increases in oxygen extraction during rapidly fatal septic shock in rats. J Lab Clin Med 1987; 109: 660–4.
   PubMed Web of Science ®Google Scholar
• Levy B, Bollaert PE, Charpentier C, Nace L, Audibert G, Bauer P, et al. Comparison of norepinephrine and dobutamine to epinephrine for hemodynamics, lactate metabolism, and gastric tonometric variables in septic shock: a prospective, randomised study. Intensive Care Med 1997; 23: 282–7.
   PubMed Web of Science ®Google Scholar
• Cumming AD, Driedger AA, McDonald JW, Lindsay RM, Solez K, Linton AL. Vasoactive hormones in the renal response to systemic sepsis. Am J Kidney Dis 1988; 11: 363.
   Web of Science ®Google Scholar
• Landry DW, Oliver JA. The pathogenesis of vasodilatory shock. N Engl J Med 2001; 345: 588–95.
   PubMed Web of Science ®Google Scholar
• Bersten AD, Hersch M, Cheung H, Rutledge FS, Sibbald WJ. The effect of various sympathomimetics on the regional circulations in hyperdynamic sepsis. Surgery 1992; 112: 549–61.
   PubMed Web of Science ®Google Scholar
• Sibbald WJ, Paterson NA, Holliday RL, Anderson RA, Lobb TR, Duff JR. Pulmonary hypertension in sepsis: Measurement by the pulmonary artery diastolic-pulmonary wedge pressure gradient and the influence of passive and active factors. Chest 1978; 73: 583–91.
   PubMed Web of Science ®Google Scholar
• Hinshaw LB, Archer LT, Spitzer JJ, Black MR, Peyton MD, Greenfield U. Effects of coronary hypotension and endotoxin on myocardial performance. Am J Physiol 1974; 227: 1051–7.
   PubMedGoogle Scholar
• Elkins RC, McCurdy JR, Brown PP, Greenfield U. Effects of coronary perfusion pressure on myocardial performance during endotoxic shock. Surg Gynecol Obstet 1976; 137: 991–6.
   Google Scholar
• Cunnion RE, Schaer GL, Parker MM, Natanson C, Parrillo P. The coronary circulation in human septic shock. Circula-tion 1986; 73: 637–44.
   PubMed Web of Science ®Google Scholar
• Dhainaut JF, Huyghebaert MF, Monsallier JF, Lefevre G, Dall'Ava-Santucci J, Brunet F, et al. Coronary hemodynamics and myocardial metabolism of lactate, free fatty acids, glucose, and ketones in patients with septic shock. Circulation 1987; 75: 533–41.
   PubMed Web of Science ®Google Scholar
• Kumar A, Thota V, Dee L, Olson J, Uretz E, Parrillo JE. Tumor necrosis factor alpha and interleukin-1 are responsible for in vitro myocardial depression induced by human septic shock. J Exp Med 1996; 183: 949–58.
   PubMed Web of Science ®Google Scholar
• Parker MM, ognibene FP, Parrillo JE. Reversible depression of myocardial function in septic shock confirmed by a load-independent measure of ventricular performance. Clin Res 1990; 38: 340A.
   Google Scholar
• Parker MM, Suffredini AF, Natanson C. Responses of left ventricular function in survivors and nonsurvivors of septic shock. J Crit Care 1989; 4: 19–25.
   Web of Science ®Google Scholar
• Friedman G, Berlot G, Kahn R J. Combined measurements of blood lactate levels and gastric intramucosal pH in patients with severe sepsis. Crit Care Med 1995; 23: 1184–93.
   PubMed Web of Science ®Google Scholar
• Vincent JL, Dufaye P, Berm J. Serial lactate determinations during circulatory shock. Crit Care Med 1983; 11: 449–51.
   PubMed Web of Science ®Google Scholar
• Marik PE. Gastric intramucosal pH. A better predictor of multi-organ dysfunction syndrome and death than oxygen-derived variables in patients with sepsis. Chest 1993; 104: 225–9.
   PubMed Web of Science ®Google Scholar
• Maynard N, Bihari D, Beale R, Smithies M, Baldock G, Mason R, et al. Assessment of splanchnic oxygenation by gastric tonometry in patients with acute circulatory failure. JAMA 1993; 270: 1203–10.
   PubMed Web of Science ®Google Scholar
• Gomersall CD, Joynt GM, Freebairn RC, Hung V, Buckley TA, Oh TE. Resuscitation of critically ill patients based on the results of gastric tonometry: a prospective, randomized, controlled trial. Crit Care Med 2000; 28: 607–14.
   PubMed Web of Science ®Google Scholar
• Astiz ME, Galera-Santiago A, Rackow EC. Intravascular volume and fluid therapy for severe sepsis. New Horiz 1993; 1: 127–36.
   PubMedGoogle Scholar
• Task force of the American College of Critical Care Medicine, Society of Critical Care Medicine. Practice parameters for hemodynamic support of sepsis in adult patients in sepsis. Crit Care Med 1999; 23: 639–60.
   Google Scholar
• Rackow EC, Falk JL, Fein IA. Fluid resuscitation in shock: A comparison of cardiorespiratory effects of albumin, hetastarch and saline solutions in patients with hypovoletnic shock. Crit Care Med 1983; 11: 839–50.
   PubMed Web of Science ®Google Scholar
• Schortgen F, Lacherade JC, Bruneel F, Cattaneo I, Hemery F, Lemaire F, et al. Effects of hydroxyethylstarch and gelatin on renal function in severe sepsis: a multicentre randomised study. Lancet 2001; 357: 911–6.
   PubMed Web of Science ®Google Scholar
• Hebert PC, Wells G, Blajchman MA, Marshall J, Martin C, Pagfiarello G, et al. A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. Transfusion Requirements in Critical Care Investigators, Canadian Critical Care Trials Group. N Engl J Med 1999; 340: 409–17.
   PubMed Web of Science ®Google Scholar
• Hebert PC, Yetisir E, Martin C, Blajchman MA, Wells G, Marshall J, et al. Is a low transfusion threshold safe in critically ill patients with cardiovascular diseases? Transfusion Requirements in Critical Care Investigators, Canadian Critical Care Trials Group. Crit Care Med 2001; 29: 227–34.
   PubMed Web of Science ®Google Scholar
• Mann C, Eon B, Saux P, Aknin P, Gouin F. Renal effects of norepinephrine used to treat septic shock patients. Crit Care Med 1990; 18: 282–5.
   PubMed Web of Science ®Google Scholar
• Meadows D, Edwards JD, Wilkins RG, Nightingale P. Reversal of intractable septic shock with norepinephrine therapy. Crit Care Med 1988; 16: 663–7.
   PubMed Web of Science ®Google Scholar
• Redl-Wenzl EM, Armbruster C, Edelmann G, Fischl E, Kolacny M, Wechsler-Fordos A, et al. The effects of norepinephrine on hemodynamics and renal function in severe septic shock states. Intensive Care Med 1993; 19: 151–4.
   PubMed Web of Science ®Google Scholar
• Hayes MA, Timmins AC, Yau EH, Palazzo M, Hinds CJ, Watson D. Elevation of systemic oxygen delivery in the treatment of critically ill patients. N Engl J Med 1994; 330: 1717–22.
   PubMed Web of Science ®Google Scholar
• Astiz M, Rackow E. Septic shock. Lancet 1998; 351: 1501–5.
   PubMed Web of Science ®Google Scholar
• LeDoux D, Astiz ME, Carpati CM, Rackow EC. Effects of perfusion pressure on tissue perfusion in septic shock. Crit Care Med 2000; 28: 2729–32.
   PubMed Web of Science ®Google Scholar
• Ruokonen E, Takala J, Kari A, Saxen H, Mertsola J, Hansen EJ. Regional blood flow and oxygen transport in septic shock. Crit Care Med 1993; 21: 1296–303.
   PubMed Web of Science ®Google Scholar
• Silva E, DeBacker D, Creteur J, Vincent JL. Effects of vasoactive drugs on gastric intramucosal pH. Crit Care Med 1998; 26: 1749–58.
   PubMed Web of Science ®Google Scholar
• MacGregor DA, Smith TE, Prielipp RC, Butterworth JF, James RU, Scuderi PE. Pharmacokinetics of dopamine in healthy male subjects. Anesthesiology 2000; 92: 338–46.
   PubMed Web of Science ®Google Scholar
• Lipman J, Roux A, Kraus P. Vasoconstrictor effects of adrenaline in human septic shock. Anaesth Intensive Care 1991; 19: 61–5.
   PubMed Web of Science ®Google Scholar
• Martin C, Viviand X, Leone M, Thirion X. Effect of norepinephrine on the outcome of septic shock. Crit Care Med 2000; 28: 2758–65.
   PubMed Web of Science ®Google Scholar
• Tuchschmidt J, Fried J, Astiz M, Rackow E. Elevation of cardiac output and oxygen delivery improves outcome in septic shock. Chest 1992; 102: 216–20.
   PubMed Web of Science ®Google Scholar
• Yu M, Levy MM, Smith P, Takiguchi SA, Miyasaki A, Myers SA. Effect of maximizing oxygen delivery on morbidity and mortality in critically ill patients: a prospective, rando-mised, controlled study. Crit Care Med 1993; 21: 830–8.
   PubMed Web of Science ®Google Scholar
• Gattinoni L, Brazzi L, Pelosi P, Latini R, Tognoni G, Pesenti A, et al. A trial of goal-oriented hemodynamic therapy in critically ill patients. N Engl J Med 1995; 333: 1025–32.
   PubMed Web of Science ®Google Scholar
• Heyland DK, Cook DJ, King D, Kernerman P, Brun-Buisson C. Maximizing oxygen delivery in critically ill patients: A methodological appraisal of the evidence. Crit Care Med 1996; 24: 517–24.
   PubMed Web of Science ®Google Scholar
• Rivers E, Nguyen B, Havstad S, Ressler J, Muzzin A, Knoblich B, et al. Early Goal-Directed Therapy Collaborative Group. Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med 2001; 345: 1368–77.
   PubMed Web of Science ®Google Scholar
• Malay MB, Ashton RC Jr, Landry DW, Townsend RN. Low-dose vasopressin in the treatment of vasodilatory septic shock. J Trauma 1999; 47: 699–703.
   PubMed Web of Science ®Google Scholar
• Patel BM, Chittock DR, Russell JA, Walley KR. Beneficial effects of short-term vasopressin infusion during severe septic shock. Anesthesiology 2002; 96: 576–82.
   PubMed Web of Science ®Google Scholar
• Dunser MW, Mayr AJ, Ulmer H, Ritsch N, Knotzer H, Pajk W, et al. The effects of vasopressin on systemic hemodynamics in catecholamine-resistant septic and postcar-diotomy shock: a retrospective analysis. Anesth Analg 2001; 93: 7–13.
   PubMed Web of Science ®Google Scholar
• Zaloga GP, Marik P. Hypothalamic-pituitary-adrenal insuffi-ciency. Crit Care Clin 2001; 17: 25–41.
   PubMed Web of Science ®Google Scholar
• Lamberts SWJ, Bruining HA, de Jong FH. Cortico steroid therapy in severe illness. N Engl J Med 1997; 337: 1285–92.
   PubMed Web of Science ®Google Scholar
• Annane D. Corticosteroids for septic shock. Crit Care Med 2001; 29(S7): S117–20.
   PubMedGoogle Scholar
• Vennes I, Beishuizen A, Hampsink RM, Haanen C. Dissociation of plasma adrenocorticotropin and cortisol levels in critically ill patients: possible role of endothelin and atrial natriuretic hormone. J Clin Endocrinol Metab 1995: 80: 1238–42.
   PubMed Web of Science ®Google Scholar
• Rydvall A, Brandström A-K, Banga R, Asplund K, Bävk-lund U, Stegmayr BG. Plasma cortisol in often decreased in patients treated in an intensive care unit. Intensive Care Med 2000; 26: 545–51.
   PubMed Web of Science ®Google Scholar
• Moran JL, Chapman MJ, O'Fathartaigh MS, Peisach AR, Pannall AR, Leppard P. Hypocortisolaemia and adrenocor-tical responsiveness at onset of septic shock. Intensive Care Med 1994; 20: 489–95.
   PubMed Web of Science ®Google Scholar
• Voerman HJ, Strack van Schijndel RJ, Groeneveld AB, de Boer H, Nauta JP, Thijs LG. Pulsatile hormone secretion during severe sepsis: accuracy of different blood sampling regimens. Metabolism 1992; 41: 93110.
   Web of Science ®Google Scholar
• Annane D, Sébille V, Troché, Raphaël J-C, Gajdos P, Bellissant P. A 3-level prognostic classification in septic shock based on cortisol levels and cortisol response to corticotropin. JAMA 2000; 283: 1038–45.
   PubMed Web of Science ®Google Scholar
• Oppert M, Reinicke A, Graf K-J, Barckow D, Frei U, Eckardt K-U. Plasma cortisol levels before and during "low-dose" hydrocortisone therapy and their relatioship to hemo-dynamic improvement in patients with septic shock. Intensive Care Med 2000; 26: 1747–55.
   PubMed Web of Science ®Google Scholar
• Spijkstra JJ, Girbes ARJ. The continuing story of corticosteroids in the treatment of septic shock. Intensive Care Med 2000; 26: 496–500.
   PubMed Web of Science ®Google Scholar
• Bouachour G, Roy P-M, Guiraud M-P. The repetitive short corticotropin stimulation test in patients with septic shock. Ann Intern Med 1995; 123: 962.
   PubMed Web of Science ®Google Scholar
• Lee WL, Downey GP. Coagulation inhibitors in sepsis and disseminated intravascular coagulation. Intensive Care Med 2000; 26: 1701–6.
   PubMed Web of Science ®Google Scholar
• Bone RC, Fisher CJ, Clemmer TP, Slotrnann GJ, Metz CA, Balk RA. A controlled clinical trial of high-dose methylpred-nisolone in the treatment of severe sepsis and septic shock. N Engl J Med 1987; 317: 653–8.
   PubMed Web of Science ®Google Scholar
• The veterans administration systemic sepsis cooperative study group. Effect of high-dose glucocorticoid therapy on mortality in patients with clinical signs of systemic sepsis. N Engl J Med 1987; 317: 659–65.
   PubMed Web of Science ®Google Scholar
• Lefering R, Neugebauer EA. Steroid controversy in sepsis and septic shock: a meta-analysis. Crit Care Med 1995; 23: 1294–303.
   PubMed Web of Science ®Google Scholar
• Cronin J, Cook DJ, Carlet J, Heyland DK, King D, Lansang MA, et al. Corticosteroid treatment for sepsis: a critical appraisal and meta-analysis of the literature. Crit Care Med 1995; 23: 1430–9.
   PubMed Web of Science ®Google Scholar
• Bollaert P-E, Charpentier C, Levy B, Debouverie M, Audibert G, Larcan A. Reversal of late septic shock with supraphysiologic doses of hydrocortisone. Crit Care Med 1998; 26: 645–50.
   PubMed Web of Science ®Google Scholar
• Briegel J, Forst H, Haller M, Schelling G, Kilger E, Kuprat G, et al. Stress doses of hydrocortisone reverse hyperdynamic septic shock: a prospective, randomized, double blind, single-center study. Crit Care Med 1999; 27: 723–32.
   PubMed Web of Science ®Google Scholar
• Annane D, Sébille V, Charpentier C, Bollaert P-E, Francois B, Korach J-H, et al. Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock. JAMA 2002; 288: 862–71.
   PubMed Web of Science ®Google Scholar
• Warren BL, Eid A, Singer P, Pillay SS, Carl P, Novak I, et al. Caring for the critically ill patient. High-dose antithrombin III in severe sepsis: a randomized controlled trial. JAMA 2001; 286: 1869–78.
   PubMed Web of Science ®Google Scholar
• Bernard GR, Vincent J-L, Laterre P-F, LaRosa SP, Dhainaut J-F, Lopez-Rodriguez A, et al. Efficacy and safety of recombinant human activated protein C for severe sepsis. N Engl J Med 2001; 344: 699–709.
   PubMed Web of Science ®Google Scholar